Keysight Technologies Set to Join S&P 500; Ligand Pharmaceuticals to Join S&P MidCap 400; Marcus & Millichap and Arcosa to Join S&P SmallCap 600

Stock Information for KraneShares MSCI All China Health Care Index ETF

Loading

Please wait while we load your information from QuoteMedia.